Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Efficient Production of Homogeneous Lysine-Based Antibody Conjugates Using Microbial Transglutaminase.

Spidel JL, Albone EF.

Methods Mol Biol. 2019;2033:53-65. doi: 10.1007/978-1-4939-9654-4_5.

PMID:
31332747
2.

Specific loss of adipocyte CD248 improves metabolic health via reduced white adipose tissue hypoxia, fibrosis and inflammation.

Petrus P, Fernandez TL, Kwon MM, Huang JL, Lei V, Safikhan NS, Karunakaran S, O'Shannessy DJ, Zheng X, Catrina SB, Albone E, Laine J, Virtanen K, Clee SM, Kieffer TJ, Noll C, Carpentier AC, Johnson JD, Rydén M, Conway EM.

EBioMedicine. 2019 Jun;44:489-501. doi: 10.1016/j.ebiom.2019.05.057. Epub 2019 Jun 17.

3.

MORAb-202, an Antibody-Drug Conjugate Utilizing Humanized Anti-human FRα Farletuzumab and the Microtubule-targeting Agent Eribulin, has Potent Antitumor Activity.

Cheng X, Li J, Tanaka K, Majumder U, Milinichik AZ, Verdi AC, Maddage CJ, Rybinski KA, Fernando S, Fernando D, Kuc M, Furuuchi K, Fang F, Uenaka T, Grasso L, Albone EF.

Mol Cancer Ther. 2018 Dec;17(12):2665-2675. doi: 10.1158/1535-7163.MCT-17-1215. Epub 2018 Sep 27.

PMID:
30262588
4.

Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagement.

Kline JB, Kennedy RP, Albone E, Chao Q, Fernando S, McDonough JM, Rybinski K, Wang W, Somers EB, Schweizer C, Grasso L, Nicolaides NC.

Oncotarget. 2017 Jul 7;8(32):52045-52060. doi: 10.18632/oncotarget.19090. eCollection 2017 Aug 8.

5.

Site-Specific Conjugation to Native and Engineered Lysines in Human Immunoglobulins by Microbial Transglutaminase.

Spidel JL, Vaessen B, Albone EF, Cheng X, Verdi A, Kline JB.

Bioconjug Chem. 2017 Sep 20;28(9):2471-2484. doi: 10.1021/acs.bioconjchem.7b00439. Epub 2017 Sep 6.

PMID:
28820579
6.

Engineering humanized antibody framework sequences for optimal site-specific conjugation of cytotoxins.

Spidel JL, Albone EF, Cheng X, Vaessen B, Jacob S, Milinichik AZ, Verdi A, Kline JB, Grasso L.

MAbs. 2017 Aug/Sep;9(6):907-915. doi: 10.1080/19420862.2017.1330734. Epub 2017 May 25.

7.

Correlation of FCGRT genomic structure with serum immunoglobulin, albumin and farletuzumab pharmacokinetics in patients with first relapsed ovarian cancer.

O'Shannessy DJ, Bendas K, Schweizer C, Wang W, Albone E, Somers EB, Weil S, Meredith RK, Wustner J, Grasso L, Landers M, Nicolaides NC.

Genomics. 2017 Jul;109(3-4):251-257. doi: 10.1016/j.ygeno.2017.04.006. Epub 2017 Apr 25.

8.

Generation of therapeutic immunoconjugates via Residue-Specific Conjugation Technology (RESPECT) utilizing a native cysteine in the light chain framework of Oryctolagus cuniculus.

Albone EF, Spidel JL, Cheng X, Park YC, Jacob S, Milinichik AZ, Vaessen B, Butler J, Kline JB, Grasso L.

Cancer Biol Ther. 2017 May 4;18(5):347-357. doi: 10.1080/15384047.2017.1312232. Epub 2017 Apr 10.

9.

Novel antibody probes for the characterization of endosialin/TEM-1.

O'Shannessy DJ, Smith MF, Somers EB, Jackson SM, Albone E, Tomkowicz B, Cheng X, Park Y, Fernando D, Milinichik A, Kline B, Fulton R, Oberoi P, Nicolaides NC.

Oncotarget. 2016 Oct 25;7(43):69420-69435. doi: 10.18632/oncotarget.11018.

10.

Derivatization of agelastatin A leading to bioactive analogs and a trifunctional probe.

Jouanneau M, McClary B, Reyes JC, Chen R, Chen Y, Plunkett W, Cheng X, Milinichik AZ, Albone EF, Liu JO, Romo D.

Bioorg Med Chem Lett. 2016 Apr 15;26(8):2092-7. doi: 10.1016/j.bmcl.2016.02.051. Epub 2016 Feb 23.

11.

Targeting endosialin/CD248 through antibody-mediated internalization results in impaired pericyte maturation and dysfunctional tumor microvasculature.

Rybinski K, Imtiyaz HZ, Mittica B, Drozdowski B, Fulmer J, Furuuchi K, Fernando S, Henry M, Chao Q, Kline B, Albone E, Wustner J, Lin J, Nicolaides NC, Grasso L, Zhou Y.

Oncotarget. 2015 Sep 22;6(28):25429-40. doi: 10.18632/oncotarget.4559.

12.

Co-development of diagnostic vectors to support targeted therapies and theranostics: essential tools in personalized cancer therapy.

Nicolaides NC, O'Shannessy DJ, Albone E, Grasso L.

Front Oncol. 2014 Jun 13;4:141. doi: 10.3389/fonc.2014.00141. eCollection 2014. Review.

13.

The antitumor activity of the human FOLR1-specific monoclonal antibody, farletuzumab, in an ovarian cancer mouse model is mediated by antibody-dependent cellular cytotoxicity.

Lin J, Spidel JL, Maddage CJ, Rybinski KA, Kennedy RP, Krauthauser CL, Park YC, Albone EF, Jacob S, Goserud MT, Martinez BP, Chao Q, Zhou Y, Nicolaides NC, Kline JB, Grasso L.

Cancer Biol Ther. 2013 Nov;14(11):1032-8. doi: 10.4161/cbt.26106. Epub 2013 Aug 28.

14.

Bioconjugation by native chemical tagging of C-H bonds.

Zhou Q, Gui J, Pan CM, Albone E, Cheng X, Suh EM, Grasso L, Ishihara Y, Baran PS.

J Am Chem Soc. 2013 Sep 4;135(35):12994-7. doi: 10.1021/ja407739y. Epub 2013 Aug 22.

15.

Characterization of the human folate receptor alpha via novel antibody-based probes.

O'Shannessy DJ, Somers EB, Albone E, Cheng X, Park YC, Tomkowicz BE, Hamuro Y, Kohl TO, Forsyth TM, Smale R, Fu YS, Nicolaides NC.

Oncotarget. 2011 Dec;2(12):1227-43.

16.

Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody.

Shin IS, Lee SM, Kim HS, Yao Z, Regino C, Sato N, Cheng KT, Hassan R, Campo MF, Albone EF, Choyke PL, Pastan I, Paik CH.

Nucl Med Biol. 2011 Nov;38(8):1119-27. doi: 10.1016/j.nucmedbio.2011.05.003. Epub 2011 Jul 7.

17.

Generation and characterization of high affinity human monoclonal antibodies that neutralize staphylococcal enterotoxin B.

Drozdowski B, Zhou Y, Kline B, Spidel J, Chan YY, Albone E, Turchin H, Chao Q, Henry M, Balogach J, Routhier E, Bavari S, Nicolaides NC, Sass PM, Grasso L.

J Immune Based Ther Vaccines. 2010 Dec 21;8:9. doi: 10.1186/1476-8518-8-9.

18.

Single dose GLP-1-Tf ameliorates myocardial ischemia/reperfusion injury.

Matsubara M, Kanemoto S, Leshnower BG, Albone EF, Hinmon R, Plappert T, Gorman JH 3rd, Gorman RC.

J Surg Res. 2011 Jan;165(1):38-45. doi: 10.1016/j.jss.2009.03.016. Epub 2009 Apr 16.

19.

Characterization of antibodies to CA 125 that bind preferentially to the cell-associated form of the antigen.

Singleton J, Guillen DE, Scully MS, Xue J, Moffet J, Chen C, Patel SR, Schilling A, Corisdeo S, Yang Q, Wang B, Soltis DA, Albone EF.

Tumour Biol. 2006;27(3):122-32. Epub 2006 Apr 11.

PMID:
16612145
20.

Synergistic effects of combined therapy using paclitaxel and [90Y-DOTA]776.1 on growth of OVCAR-3 ovarian carcinoma xenografts.

Masters GR, Berger MA, Albone EF.

Gynecol Oncol. 2006 Sep;102(3):462-7. Epub 2006 Jan 24.

PMID:
16434088
21.

Pharmacokinetics, biodistribution, and radioimmunotherapy with monoclonal antibody 776.1 in a murine model of human ovarian cancer.

Berger MA, Masters GR, Singleton J, Scully MS, Grimm LG, Soltis DA, Albone EF.

Cancer Biother Radiopharm. 2005 Dec;20(6):589-602.

PMID:
16398611
22.

Radiotherapy of human xenograft NSCLC tumors in nude mice with a 90Y-labeled anti-tissue factor antibody.

Wang B, Berger M, Masters G, Albone E, Yang Q, Sheedy J, Kirksey Y, Grimm L, Wang B, Singleton J, Soltis D.

Cancer Biother Radiopharm. 2005 Jun;20(3):300-9.

PMID:
15989475
23.

Molecular cloning and characterization of the gene encoding rat submandibular gland apomucin, Mucsmg.

Albone EF, Hagen FK, Szpirer C, Tabak LA.

Glycoconj J. 1996 Oct;13(5):709-16.

PMID:
8909997
24.

Characterization of an RNase H deficient mutant of human immunodeficiency virus-1 reverse transcriptase having an aspartate to asparagine change at position 498.

DeStefano JJ, Wu W, Seehra J, McCoy J, Laston D, Albone E, Fay PJ, Bambara RA.

Biochim Biophys Acta. 1994 Oct 18;1219(2):380-8.

PMID:
7522572
25.

Molecular cloning of a rat submandibular gland apomucin.

Albone EF, Hagen FK, VanWuyckhuyse BC, Tabak LA.

J Biol Chem. 1994 Jun 17;269(24):16845-52.

26.
27.

5-Aminovaleric acid, a major free amino acid component of the anal sac secretion of the red fox, Vulpes vulpes.

Albone ES, Robins SP, Patel D.

Comp Biochem Physiol B. 1976;55(4):483-6. No abstract available.

PMID:
1000937
28.

Dihydroactinidiolide in the supracaudal scent gland secretion of the red fox.

Albone ES.

Nature. 1975 Aug 14;256(5518):575. No abstract available.

PMID:
1165772
29.

The anal sac secretion of the red fox (Vulpes vulpes); its chemistry and microbiology. A comparison with the anal sac secretion of the lion (Panthera leo).

Albone ES, Eglinton G, Walker JM, Ware GC.

Life Sci. 1974 Jan 16;14(2):387-400. No abstract available.

PMID:
4813597
30.

Anal gland secretion of the red fox.

Albone ES, Fox MW.

Nature. 1971 Oct 22;233(5321):569-70. No abstract available.

PMID:
4939989

Supplemental Content

Loading ...
Support Center